US Patent 11746161 Antibodies that specifically bind PD-1 and methods of use
Patent 11746161 was granted and assigned to Janssen Biotech on September, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+26 properties)
Article (+243 characters)
US Patent 11746161 Antibodies that specifically bind PD-1 and methods of use
Article
Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11746161
Patent Inventor Names
Ann Lacombe
Damon Hamel
Debra Gardner
Deepti Wilkinson
Jinquan Luo
Karen Duffy
Melissa Swiecki
Pejman Soroosh
Qiang Chen
Ravi Malaviya
Shannon Hitchcock
Suzanne Cole
Yanxia Guo
Yevgeniya Orlovsky
Date of Patent
September 5, 2023
Patent Application Number
17125263
Date Filed
December 17, 2020
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11746161 Antibodies that specifically bind PD-1 and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
